SCHEMBL22079887

SCHEMBL22079887

CCNC(=O)c1cnc(NS(=O)(=O)c2ccc(OC(C)(C)CC(C)(C)C(=O)O)cc2)nc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.48
▸ HTT P42858 1/20 0.41
▸ SCN3A Q9NY46 1/20 0.40
▸ LMNA P02545 2/20 0.38
▸ POLB P06746 2/20 0.38
▸ HDAC3 O15379 1/20 0.38
▸ HDAC4 P56524 1/20 0.38
▸ HDAC1 Q13547 1/20 0.38
▸ HDAC7 Q8WUI4 1/20 0.38
▸ HDAC2 Q92769 1/20 0.38
▸ HDAC10 Q969S8 1/20 0.38
▸ HDAC11 Q96DB2 1/20 0.38
▸ HDAC8 Q9BY41 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38
▸ HDAC9 Q9UKV0 1/20 0.38
▸ HDAC5 Q9UQL6 1/20 0.38
▸ HPGDS O60760 1/20 0.38
▸ GHSR Q92847 1/20 0.37
▸ TP53 P04637 3/20 0.37
▸ THRB P10828 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22079889 0.89 HDAC3 (0.46) TDP1HTTSCN3AHDAC3HDAC4
SCHEMBL22080313 0.89 TDP1 (0.48) TDP1HTTSCN3ALMNAPOLB
SCHEMBL24257946 0.84 TDP1 (0.44) TDP1SCN3ALMNAPOLBHDAC3
SCHEMBL24257969 0.81 TDP1 (0.44) TDP1SCN3ALMNAPOLBHDAC3
SCHEMBL24257942 0.78 TDP1 (0.39) TDP1LMNAPOLBHDAC3HDAC4
SCHEMBL22080249 0.76 TDP1 (0.41) TDP1HTTTP53MAPT
SCHEMBL22079886 0.74 TDP1 (0.43) TDP1HTTLMNAPOLBHPGDS
SCHEMBL24257947 0.73 TDP1 (0.35) TDP1LMNAPOLBTP53
SCHEMBL22079982 0.72 TDP1 (0.52) TDP1HTTLMNAMEN1KMT2A
SCHEMBL24257721 0.72 TDP1 (0.34) TDP1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048968-A1 INSULIN CONJUGATES SANOFI (FR) 2022-02-17 — — US disclosed
US-20200181223-A1 INSULIN CONJUGATES SANOFI (FR) 2020-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200181223-A1 INSULIN CONJUGATES IAPP, INSR, IGF1R TDP1 4783/4885HTT 855/4885SCN3A 909/4885
US-20220048968-A1 INSULIN CONJUGATES IAPP, INSR, IGF1R TDP1 4783/4885HTT 855/4885SCN3A 909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback